Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Weakness, Fatigue Can Signal Underlying Rheumatologic Disease

Simon M. Helfgott, MD  |  Issue: April 2017  |  April 17, 2017

When I first met Betty, now wheelchair bound, she could barely recount her history. “I am just too tired to talk, doctor. Can I come back another day?”

Something was amiss; her extreme somnolence and lethargy, her deepening voice could not be linked to lupus. The mystery was solved when her circulating serum thyroxine level was barely detectable and her serum thyroid-stimulating hormone level returned in the stratospheric range, 250 units (normal up to 5 units): a classic example of a functioning endocrine feedback loop. Betty was, literally, hours away from descending into myxedema coma.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Many months later, following Betty’s recovery, it became evident that her prior diagnosis of lupus was in error. Her weakness, lethargy, full facies, thinning hair, general malaise and positive ANA masqueraded as lupus when, in fact, these findings could all be attributed to another autoimmune disorder: hypothyroidism caused by Hashimoto’s disease that had annihilated her thyroid gland years earlier. Although she had taken thyroxine for years, it was mistakenly discontinued when she changed primary care doctors. She was advised that it was no longer required—a near fatal error.

The thyroid–muscle interaction can be double edged. A sluggish or an overactive thyroid gland can profoundly influence muscle strength. The latter holds true for thyrotoxic periodic paralysis, a disorder observed in about 15% of Asian men with hyperthyroidism characterized by the abrupt onset of hypokalemia and paralysis primarily affecting the legs.4 Patients are literally stopped in their tracks until the episode of profound weakness resolves.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

My brush with this illness occurred years ago when, as a medical resident, I examined a Korean postdoctoral mathematics student who was referred to neurology clinic for his episodic weakness. Living on a tight budget, he described a weekly ritual of consuming as many as six bowls of pasta every Tuesday night at a neighborhood all-you-can-eat restaurant, and he noticed that he would be unable to rise out of bed every Wednesday morning. He adapted to the situation by lying in bed for about an hour, patiently solving quadratic equations, waiting for his legs to recover so that he could start moving again.

The high-carbohydrate load of bowls of pasta can trigger a surfeit of insulin secretion that in turn stimulates excess Na+/K+ ATPase activity in muscle cells, causing a dramatic drop in potassium that renders the muscles dysfunctional.4 Next time, may I suggest a bowl of kimchi?

Muscle & Bone

Our skeletons influence our strength. It has long been observed that osteomalacia due to severe vitamin D deficiency can be associated with weakness. Similarly, patients with cancer that has metastasized to bone are often weaker than one would expect based on the skeletal location of their lesions. Why?

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsOpinionRheuminationsSpeak Out Rheum Tagged with:Diagnosisfatigueillnessinflammatory myositisLupusMyopathyOsteoarthritisoutcomepatient careRheumatic DiseaserheumatologistthyroidTreatmentweakness

Related Articles

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    Case Report: Tumor Treatment Unleashes Autoimmunity

    November 17, 2019

    Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) or programmed cell death protein 1 (PD-1) axes have revolutionized therapy and improved survival in advanced cancers. However, these immune system modulators also lead to immune-related adverse events (IRAEs).1,2 In clinical trials, IRAEs mainly involved the gastrointestinal tract, skin, endocrine glands, liver and lung,…

    Rehabilitation and Myositis

    January 1, 2008

    Physical therapy to manage inflammatory muscle disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences